vs
AYTU BIOPHARMA, INC（AYTU）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
AYTU BIOPHARMA, INC的季度营收约是RIVERVIEW BANCORP INC的1.1倍（$15.2M vs $14.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -69.8%，领先79.6%），RIVERVIEW BANCORP INC同比增速更快（10.4% vs -6.5%），AYTU BIOPHARMA, INC自由现金流更多（$3.7M vs $-736.0K），过去两年RIVERVIEW BANCORP INC的营收复合增速更高（24.6% vs 4.0%）
AYTU生物制药是一家总部位于美国的特种制药企业，研发并商业化消费级健康产品与处方治疗药物，产品线覆盖感冒过敏用药、生殖健康解决方案及罕见儿科疾病治疗药物，服务美国本土患者与医疗服务提供者。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
AYTU vs RVSB — 直观对比
营收规模更大
AYTU
是对方的1.1倍
$14.0M
营收增速更快
RVSB
高出16.9%
-6.5%
净利率更高
RVSB
高出79.6%
-69.8%
自由现金流更多
AYTU
多$4.4M
$-736.0K
两年增速更快
RVSB
近两年复合增速
4.0%
损益表 — Q2 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $15.2M | $14.0M |
| 净利润 | $-10.6M | $1.4M |
| 毛利率 | 63.5% | — |
| 营业利润率 | -13.0% | 12.4% |
| 净利率 | -69.8% | 9.8% |
| 营收同比 | -6.5% | 10.4% |
| 净利润同比 | -1443.1% | 11.8% |
| 每股收益（稀释后） | $-1.05 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AYTURVSB
| Q4 25 | $15.2M | $14.0M | ||
| Q3 25 | $13.9M | $13.6M | ||
| Q2 25 | $15.1M | $13.3M | ||
| Q1 25 | $18.5M | $12.9M | ||
| Q4 24 | $16.2M | $12.7M | ||
| Q3 24 | $16.6M | $12.8M | ||
| Q2 24 | $14.6M | $12.2M | ||
| Q1 24 | $14.0M | $9.0M |
净利润AYTURVSB
| Q4 25 | $-10.6M | $1.4M | ||
| Q3 25 | $2.0M | $1.1M | ||
| Q2 25 | $-19.8M | $1.2M | ||
| Q1 25 | $4.0M | $1.1M | ||
| Q4 24 | $788.0K | $1.2M | ||
| Q3 24 | $1.5M | $1.6M | ||
| Q2 24 | $-4.6M | $966.0K | ||
| Q1 24 | $-2.9M | $-3.0M |
毛利率AYTURVSB
| Q4 25 | 63.5% | — | ||
| Q3 25 | 66.1% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 69.4% | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 72.3% | — | ||
| Q2 24 | 75.7% | — | ||
| Q1 24 | 73.9% | — |
营业利润率AYTURVSB
| Q4 25 | -13.0% | 12.4% | ||
| Q3 25 | -10.8% | 10.2% | ||
| Q2 25 | -50.4% | 11.7% | ||
| Q1 25 | 13.1% | 11.3% | ||
| Q4 24 | -10.4% | 12.4% | ||
| Q3 24 | -5.6% | 15.5% | ||
| Q2 24 | -15.6% | 10.0% | ||
| Q1 24 | -11.4% | -47.5% |
净利率AYTURVSB
| Q4 25 | -69.8% | 9.8% | ||
| Q3 25 | 14.1% | 8.1% | ||
| Q2 25 | -130.9% | 9.2% | ||
| Q1 25 | 21.6% | 8.9% | ||
| Q4 24 | 4.9% | 9.7% | ||
| Q3 24 | 8.9% | 12.2% | ||
| Q2 24 | -31.6% | 7.9% | ||
| Q1 24 | -20.6% | -34.7% |
每股收益（稀释后）AYTURVSB
| Q4 25 | $-1.05 | $0.07 | ||
| Q3 25 | $-0.08 | $0.05 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | $0.21 | $0.05 | ||
| Q4 24 | $-0.26 | $0.06 | ||
| Q3 24 | $-0.15 | $0.07 | ||
| Q2 24 | — | $0.05 | ||
| Q1 24 | $-0.52 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.0M | $28.6M |
| 总债务越低越好 | $10.0M | — |
| 股东权益账面价值 | $14.2M | $164.2M |
| 总资产 | $122.0M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.70× | — |
8季度趋势，按日历期对齐
现金及短期投资AYTURVSB
| Q4 25 | $30.0M | $28.6M | ||
| Q3 25 | $32.6M | $32.8M | ||
| Q2 25 | $31.0M | $34.2M | ||
| Q1 25 | $18.2M | $29.4M | ||
| Q4 24 | $20.4M | $25.3M | ||
| Q3 24 | $20.1M | $31.0M | ||
| Q2 24 | $20.0M | $27.8M | ||
| Q1 24 | $19.8M | $23.6M |
总债务AYTURVSB
| Q4 25 | $10.0M | — | ||
| Q3 25 | $10.4M | — | ||
| Q2 25 | $10.9M | — | ||
| Q1 25 | $9.5M | — | ||
| Q4 24 | $10.0M | — | ||
| Q3 24 | $10.4M | — | ||
| Q2 24 | $10.9M | — | ||
| Q1 24 | $0 | — |
股东权益AYTURVSB
| Q4 25 | $14.2M | $164.2M | ||
| Q3 25 | $23.2M | $163.5M | ||
| Q2 25 | $19.0M | $162.0M | ||
| Q1 25 | $34.9M | $160.0M | ||
| Q4 24 | $30.8M | $158.3M | ||
| Q3 24 | $29.8M | $160.8M | ||
| Q2 24 | $27.7M | $155.9M | ||
| Q1 24 | $30.8M | $155.6M |
总资产AYTURVSB
| Q4 25 | $122.0M | $1.5B | ||
| Q3 25 | $125.0M | $1.5B | ||
| Q2 25 | $124.2M | $1.5B | ||
| Q1 25 | $124.2M | $1.5B | ||
| Q4 24 | $116.2M | $1.5B | ||
| Q3 24 | $115.8M | $1.5B | ||
| Q2 24 | $118.1M | $1.5B | ||
| Q1 24 | $128.9M | $1.5B |
负债/权益比AYTURVSB
| Q4 25 | 0.70× | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.57× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.35× | — | ||
| Q2 24 | 0.39× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.7M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $3.7M | $-736.0K |
| 自由现金流率自由现金流/营收 | 24.1% | -5.2% |
| 资本支出强度资本支出/营收 | 0.1% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | — | $20.4M |
8季度趋势，按日历期对齐
经营现金流AYTURVSB
| Q4 25 | $3.7M | $-506.0K | ||
| Q3 25 | $-618.0K | $16.8M | ||
| Q2 25 | $2.8M | $-697.0K | ||
| Q1 25 | $-6.5M | $8.3M | ||
| Q4 24 | $2.9M | $2.2M | ||
| Q3 24 | $-1.2M | $764.0K | ||
| Q2 24 | $-788.0K | $5.4M | ||
| Q1 24 | $-254.0K | $12.8M |
自由现金流AYTURVSB
| Q4 25 | $3.7M | $-736.0K | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $-773.0K | ||
| Q1 25 | $-6.5M | $5.6M | ||
| Q4 24 | $2.9M | $1.9M | ||
| Q3 24 | $-1.3M | $-1.4M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | $7.1M |
自由现金流率AYTURVSB
| Q4 25 | 24.1% | -5.2% | ||
| Q3 25 | — | 120.1% | ||
| Q2 25 | — | -5.8% | ||
| Q1 25 | -35.4% | 43.1% | ||
| Q4 24 | 17.9% | 15.0% | ||
| Q3 24 | -8.0% | -11.3% | ||
| Q2 24 | — | 43.7% | ||
| Q1 24 | — | 79.0% |
资本支出强度AYTURVSB
| Q4 25 | 0.1% | 1.6% | ||
| Q3 25 | 0.0% | 2.9% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | 0.4% | 21.0% | ||
| Q4 24 | 0.0% | 2.4% | ||
| Q3 24 | 0.8% | 17.3% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | 0.0% | 62.0% |
现金转化率AYTURVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | -0.31× | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | -1.62× | 7.20× | ||
| Q4 24 | 3.69× | 1.79× | ||
| Q3 24 | -0.81× | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
